AYTU
Aytu BioPharma, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$2.21
−3.28%Margins
Gross margin
62.5%
EBITDA margin
-48.3%
EBIT margin
-26.8%
Net margin
-60.2%
FCF margin
2.9%
-96.9%
Return on equity
-30.5%
Return on assets
-26.1%
Return on invested capital
0.48x
Asset turnover
$1.7M
Cash from operations
$2.49
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026